Aurinia (AUPH) EVP gets stock awards and has shares withheld for taxes

Rhea-AI Filing Summary

Aurinia Pharmaceuticals Inc. executive vice president and general counsel Stephen P. Robertson reported multiple equity transactions. On February 27, 2026, he received a grant of 98,813 employee stock options with a $0 exercise price and a separate award of 59,090 common shares, both held directly.

On March 2, 2026, 36,525 common shares were disposed of to satisfy tax withholding obligations upon vesting of restricted stock units, at a price of $14.21 per share. After these transactions, he directly owned 505,861 common shares.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Robertson Stephen P.

Role EVP, General Counsel

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	36,525	$14.21	$519K
Grant/Award	Employee Stock Option (right to buy)	98,813	$0.00	--
Grant/Award	Common Stock	59,090	$0.00	--

Holdings After Transaction: Common Stock — 505,861 shares (Direct); Employee Stock Option (right to buy) — 98,813 shares (Direct)

Footnotes (1)

1. Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement. Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Robertson Stephen P.

(Last) (First) (Middle)

#140, 14315 - 118 AVENUE

(Street)

EDMONTON A0 T5L 4S6

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aurinia Pharmaceuticals Inc. [ AUPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		59,090(1)	A	$0	542,386	D
Common Stock	03/02/2026		F		36,525(2)	D	$14.21	505,861	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$13.97	02/27/2026		A		98,813		(3)	02/27/2036	Common Stock	98,813	$0	98,813	D

Explanation of Responses:

1. Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement.

2. Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.

3. One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.

Remarks:

	/s/ Stephen P. Robertson	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Aurinia (AUPH) report for Stephen P. Robertson?

Aurinia (AUPH) reported that EVP and general counsel Stephen P. Robertson received a grant of 98,813 stock options and 59,090 common shares. He also had 36,525 shares withheld to cover tax obligations, leaving him with 505,861 common shares owned directly.

Were the Aurinia (AUPH) insider transactions open-market buys or sells?

The Form 4 for Aurinia (AUPH) shows no open-market buys or sells. It reports equity grants and a tax-withholding disposition, where 36,525 shares were withheld to satisfy tax obligations upon vesting of restricted stock units rather than sold in the market.

How many Aurinia (AUPH) stock options were granted to Stephen P. Robertson?

Stephen P. Robertson was granted 98,813 employee stock options in Aurinia (AUPH). The filing states these options were awarded at a $0 exercise price, with vesting occurring over time according to a schedule described in the accompanying footnote.

How many Aurinia (AUPH) common shares does Stephen P. Robertson hold after these transactions?

After the reported transactions, Stephen P. Robertson directly holds 505,861 Aurinia (AUPH) common shares. This figure reflects the equity grants and the 36,525 shares withheld to cover tax obligations, as disclosed in the Form 4 ownership totals.

What was the purpose of the 36,525 Aurinia (AUPH) shares disposed of on March 2, 2026?

The 36,525 Aurinia (AUPH) shares disposed of on March 2, 2026 were withheld to satisfy tax withholding obligations. The Form 4 explains these shares were used to cover taxes upon the vesting of restricted stock units, not as an open-market sale.

How do the Aurinia (AUPH) stock options granted to Stephen P. Robertson vest?

The Form 4 states that one-third of the stock options granted to Stephen P. Robertson vest twelve months from the grant date. The remaining options then vest in twenty-four equal monthly installments, creating a multi-year vesting schedule tied to continued service.